Generic Oncology Drugs Market

Generic Oncology Drugs Market: Opportunities Emerge in Developing Countries: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028

  • 2019-02-18
  • REP-GB-8961
  • PDF PPT EXCEL
 Generic Oncology Drugs Market

An Incisive, In-depth Analysis on the Generic Oncology Drugs Market

This study offers a comprehensive, 360 degree analysis on the Generic Oncology Drugs market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Generic Oncology Drugs market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.

Increasing incidences of cancer have been detected, ascending from the proclivity for cigarettes and tobacco among individuals. The number of cancer-infected patients is stimulated by viral infections, carcinogens, lack of physical activities, genetic causes, age, and unhealthy eating habits. Recent developments in the healthcare sector have broadened the scope of therapies for the treatment of cancer by leveraging oncology.

Demand for generic oncology drugs has witnessed sheer increase, by dint of its property to treat numerous types of cancer such as colorectal, lung, prostate, and in blood cancer treatment like multiple myeloma. With the ubiquity of cancer, several health organizations across the world are hard pressed to develop a potent cure for the treatment of cancer. In addition to this, a high number of deaths occurring on account of cancer has amplified the research and development endeavors of medical organizations to prevent cancer altogether.

Government initiatives to enhance the medical conditions by encouraging the development of novel drugs has been a crucial factor for the rapid expansion of the generic oncology drugs market. Furthermore, the reimbursement policies of government have equipped the manufacturers of the industry with an attractive opportunity to boost the production of generic oncology drugs, which has been a vital factor for the sustainable growth of the generic oncology drugs market. Analyzing a cohort of these factors, the global generic oncology drugs market is poised to surpass a stunning CAGR of 6.2% through 2028.

North America Enjoys a Dominant Share in the Global Generic Oncology Drugs Market; Europe and Asia-Pacific Next in Rank

Extensive analysis carried out on the generic oncology drugs market has presented region-wise insights on the demand drivers, restraints, and opportunities that influence the growth of the market. Regions analyzed in this report includes North America, Europe Asia-Pacific, and Rest of the World.

Rising awareness of novel innovations and therapies for the treatment of cancer are projected to offer lucrative growth opportunities to the generic oncology drugs market. Increase in the demand for generic oncology drugs is further intensified in North America, on account of personalized medicines, novel branded generics drugs launches and a rising rate of strategic partnerships and collaborations in this region. Following the footsteps of North America, Europe has witnessed affluent growth in the generic oncology drugs market with the increasing consciousness of the generic oncology drugs for cancer therapies.

Emerging economies of Asia-Pacific like India and China are expected to contribute to the growth of the generic oncology drugs market, owing to the increasing cognizance of the disease and advancements in the development of the generic oncology drugs.

A Look at the Competitive Matrix for the Generic Oncology Drugs Market

The report opines that the burgeoning trend of mergers and acquisitions has been witnessed in the generic oncology drugs market, which is expected to influence the growth of the global generic oncology drugs market. Key players transforming the scenario of the generic oncology drugs market are Bayer Healthcare AG, Amgen, Teva Pharmaceutical Industries, Pfizer, Boehringer Ingelheim GmbH, AstraZeneca, Hoffmann-La Roche Ltd., Eli Lily and Company, ARIAD Pharmaceuticals, Inc., GlaxoSmithKline, CELGENE Corporation, Novartis AG, Johnson and Johnson, AbbVie Inc., Merck & Co., and Sanofi, among others.

The business strategies and recent developments adopted by these players have been incorporated in the report, which will help the stakeholders of this market gain valuable insights into the competitive matrix of the global generic oncology drugs market.

Recent Developments in the Global Generic Oncology Drugs Market

CELGENE, Novartis, and Roche have been significant players in the generic oncology drugs market with their far-reaching product portfolio and pipeline products and they procure a considerable market share. Therapies and generic oncology drugs developed by Roche such as Avastin, Herceptin, and Rituxan witnessed a rapid adoption.

Strategic alliances formed by the companies of the generic oncology drugs market have aided them in intensifying their endeavors towards developing generic oncology drugs with high efficacy. These thoughtful strategies have proved lucrative for these players and helped them retain their supreme position in the generic oncology drugs market.

A new market report published by Future Market Insights (FMI) comprises of a detailed analysis of the oncology drugs market. The report studies robust demand drivers by conducting extensive research on the growth prospects.

Chapter 1: Oncology Drugs Market – Executive Summary

This study begins with an elaborate executive summary that includes a detailed overview of the oncology drugs market, crucial statistics, and key observations of the market. The valuation is done in terms of value (US$ Mn).

Chapter 2: Oncology Drugs Market – Market Introduction

With the help of this report, the stakeholders will be able to understand the taxonomy and important definition of the market.

Chapter 3: Oncology Drugs Market – Opportunity Analysis

The chapter highlights multiple factors pertaining to the growth of the market, which helps in extracting the historical data, future prospects, and current trends. It also provides an analysis of various macroeconomic and microeconomic growth drivers.

Chapter 4: Oncology Drugs Market – Background

The section of the report focuses on the restraints, trends, and demand drivers. Other key insights such as Regulatory Scenario and PESTLE Analysis are also incorporated in this study.

Chapter 5: Oncology Drugs Market – Key Inclusions

The report underlines the broad scope of the generic market in a comprehensive manner.

Chapter 6: Oncology Drugs Market – North America Generic Market Analysis for 2013 – 2017 and Prediction for 2018 – 2028

The market study comprises of an in-depth analysis of oncology drugs, besides a regional assessment including Canada and the U.S.

Chapter 7: Oncology Drugs Market – Western Europe Generic Market Analysis for 2013 – 2017 and Prediction for 2018 – 2028

The market study includes a brief analysis of oncology drugs, besides a regional assessment including France, Italy, Germany, UK, Spain, and Rest of the World.

Chapter 8: Oncology Drugs Market – Eastern Europe Generic Market Analysis for 2013 – 2017 and Prediction for 2018 – 2028

The market study comprises of a comprehensive analysis of oncology drugs, besides a regional assessment in numerous Eastern European countries.

Chapter 9: Oncology Drugs Market – Latin America Generic Market Analysis for 2013 – 2017 and Prediction for 2018 – 2028

The market study comprises of an incisive view of the market, besides a regional assessment including Mexico and Brazil.

Chapter 10: Oncology Drugs Market – APECJ Generic Market Analysis for 2013 – 2017 and Prediction for 2018 – 2028

The market study comprises of an in-depth analysis of oncology drugs, besides a regional assessment including ASEAN, India, and Australia and New Zealand.

Chapter 11: Oncology Drugs Market – China Generic Market Analysis for 2013 – 2017 and Prediction for 2018 – 2028

The market study consists of a brief analysis of oncology drugs depending on the distribution channel, route of administration, and molecule type.

Chapter 12: Oncology Drugs Market – Japan Generic Market Analysis for 2013 – 2017 and Prediction for 2018 – 2028

The market study includes a comprehensive analysis of oncology drugs based on market segmentation during the predicted period.

Chapter 13: Oncology Drugs Market – MEA Generic Market Analysis for 2013 – 2017 and Prediction for 2018 – 2028

The market study comprises of a broad analysis of oncology drugs, besides a regional assessment includingSouth Africa, GCC countries, and MEA countries.

Chapter 14: Forecast Factors of the Oncology Drugs Market – Relevance & Impact

The forecast factors for estimating the overall market are also incorporated in this report.

Chapter 15: Oncology Drugs Market – Forecast Assumption

This section of the report constitutes assumptions taken into consideration for forecasting the size of the market.

Chapter 16: Oncology Drugs Market - Competition Analysis

This chapter of the report comprises an in-depth competition analysis of the oncology drugs market, along with revenue shares, recent developments, strategic overview, and overview of the company.

Chapter 17: Oncology Drugs Market – Global Generic Market Analysis for 2013 – 2017 and Forecast for 2018 – 2028, Region-wise

The regions analyzed in this report comprise of regional analysis of MEA, China, Japan, APECJ, Eastern Europe, Western Europe, Latin America, and North America.

Chapter 18: Oncology Drugs Market – Global Generic Market Analysis for 2013 – 2017 and Forecast for 2018 – 2028, Based on Molecule Type

Depending on the type of the molecule, the market is fragmented into small molecule and large molecule.

Chapter 19: Oncology Drugs Market – Global Generic Market Analysis for 2013 – 2017 and Forecast for 2018 – 2028, Base on Route of Administration

Based on the route of administration, the market is divided into parenteral and oral.

Chapter 20: Oncology Drugs Market – Global Generic Market Analysis for 2013 – 2017 and Forecast for 2018 – 2028, Based on the Distribution Channel

Depending on the distribution channel, the market is classified into online pharmacy, retail pharmacy, managed care institutions, and hospital pharmacy.

Chapter 21: Oncology Drugs Market – Global Market Analysis & Forecast

This section of the report underlines the market value, global absolute dollar opportunity, forecast & analysis.

Chapter 22: Oncology Drugs Market: Assumptions & Acronym Used

The chapter comprises of assumptions, along with the acronyms included in this report.

Chapter 23: Oncology Drugs Market: Research Methodology

The concluding section of the report comprises crucial quantitative and qualitative information of the market.

Generic Oncology Drugs Market Reports - Table of Contents

Get in touch

Harish Tiwari

Harish Tiwari

Global Head - Business Development

Pranay Mhaisekar

Pranay Mhaisekar

Business Development

* indicates mandatory fields.

Our Clients


CASE STUDIES

See how our work makes an impact.

At FMI, we design strategies that are adaptive, impactful, and implementable.

Request Sample Ask An Analyst Request Special Price Request Methodology